Illumina, Inc. vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Illumina, Inc. trades at $190.62 (market cap $27.94B), while Direxion Daily Semiconductor Bull 3X Shares trades at $158.43. The key difference: Illumina, Inc. is trading nearer its 52-week high, Direxion Daily Semiconductor Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| ILMN | SOXL | |
|---|---|---|
Market Cap | $27.94B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $194.33 | $300.77 |
52-Week Low | $91.00 | $23.99 |
Enterprise Value | $29.33B | — |
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
SOXL trades at $136.81, up 1.24% on the day, amid a bearish technical signal with 17 sell indicators versus 7 buy. The semiconductor sector faces volatility, with recent news highlighting AI-driven demand potential but also capital expenditure concerns from major holdings like TSMC. Support sits at $127, with resistance at $144, indicating a critical juncture for near-term price action.
The outlook remains cautious due to leveraged ETF decay risks and sector-wide headwinds, though AI infrastructure growth offers long-term opportunity. Investors face elevated volatility from semiconductor cycle swings and competitive pressures, requiring careful risk management given the fund's amplified exposure.
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →